2 unknown, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow NHL, Adult: new trials by email Literature Review of NHL, Adult trials Research Report on NHL, Adult
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SynKIR-310 for Relapsed/Refractory B-NHL SynKIR-310 - B Cell Lymphoma, NHL, Adult | Phase 1 | Recruiting | Verismo Therapeutics | 36 | 2024-11-01 | 2026-04-14 |
| A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients ETH-155008 - NHL, Adult, AML, Adult Recurrent | Phase 1 | Unknown | Shengke Pharmaceuticals (Jiangsu) Limited, China | 60 | 2022-11-04 | 2024-05-08 |
| APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma APG-1252, Chidamide - NHL, Adult | Phase 1 / Phase 2 | Unknown | Ascentage Pharma Group Inc. | 51 | 2022-06-14 | 2024-01-23 |
Lymphoma, Non-Hodgkin (3) · Dendritic Cell Sarcoma, Interdigitating (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Pyloric Stenosis, Hypertrophic (1) · Recurrence (1) · Waldenstrom Macroglobulinemia (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Digestive System Diseases (1) · Disease Attributes (1) · Gastric Outlet Obstruction (1) · Gastrointestinal Diseases (1)
Drug Evaluation (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · pelcitoclax (1)
Ascentage Pharma Group Inc. (1) · Shengke Pharmaceuticals (Jiangsu) Limited, China (1) · Verismo Therapeutics (1)
China (2) · United States (1)
James Zhang (1) · Laura A Johnson, PhD (1) · Yifan Zhai, MD, PhD (1)